Curcumin analogs as potent aldose reductase inhibitors

被引:52
作者
Du, ZY
Bao, YD
Liu, Z
Qiao, W
Ma, L
Huang, ZS
Gu, LQ [1 ]
Chan, ASC
机构
[1] Sun Yat Sen Univ, Zhi Shu Huang Sch Pharmaceut Sci, Guangzhou 510980, Peoples R China
[2] Sun Yat Sen Univ, Sch Chem & Chem Engn, Guangzhou, Peoples R China
[3] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China
关键词
curcuminoids; curcumin analogs; aldose reductase inhibitors; diabetic complication;
D O I
10.1002/ardp.200500205
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In the present study, curcuminoids isolated from curcuma longa were demonstrated to possess inhibitory activities on bovine lens aldose reductase. In order to find more potent aldose reductase inhibitor, curcumin analogs were synthesized and evaluated for their ability to inhibit bovine lens aldose reductase enzyme. The results indicated that the compounds with tetrahydroxyl groups, 2,6-bis(3,4-dihydroxybenzylidene-)cyclohexanone (A(2)), 2,5-bis(3,4-dihydroxybenzylidene)cyclopentanone (B-2), 1,5-bis(3,4-dihydroxyhenyl)-1,4-pentadiene-3-one (C-2), and 3,5-bis(3,4dihydroxybenzylidene)-4-piperidone (D-2) showed remarkably potent inhibitory effects on aldose reductase with IC50 of 2.9 mu M, 2.6 mu M, 3.4 mu M, and 4.9 mu M, respectively. The structure-activity relationship revealed that the curcumin analogs with ortho-dihydroxyl groups could form a more tight affinity with aldose reductase to exert more potential inhibitory activities.
引用
收藏
页码:123 / 128
页数:6
相关论文
共 18 条
[1]   Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: Synthesis, biological evaluation, and molecular modeling [J].
Artico, M ;
Di Santo, R ;
Costi, R ;
Novellino, E ;
Greco, G ;
Massa, S ;
Tramontano, E ;
Marongiu, ME ;
De Montis, A ;
La Colla, P .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (21) :3948-3960
[2]   Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820
[3]   Pharmacological approaches to the treatment of diabetic complications [J].
Costantino, L ;
Rastelli, G ;
Gamberini, MC ;
Barlocco, D .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (08) :1245-1262
[4]  
Costantino L, 1999, MED RES REV, V19, P3, DOI 10.1002/(SICI)1098-1128(199901)19:1<3::AID-MED2>3.0.CO
[5]  
2-7
[6]   1-Benzopyran-4-one antioxidants as aldose reductase inhibitors [J].
Costantino, L ;
Rastelli, G ;
Gamberini, MC ;
Vinson, JA ;
Bose, P ;
Iannone, A ;
Staffieri, M ;
Antolini, L ;
Del Corso, A ;
Mura, U ;
Albasini, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (11) :1881-1893
[7]   Synthesis, activity, and molecular modeling of a new series of tricyclic pyridazinones as selective aldose reductase inhibitors [J].
Costantino, L ;
Rastelli, G ;
Vescovini, K ;
Cignarella, G ;
Vianello, P ;
DelCorso, A ;
Cappiello, M ;
Mura, U ;
Barlocco, D .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (22) :4396-4405
[8]   Aldose reductase inhibitors from natural sources [J].
de la Fuente, JA ;
Manzanaro, S .
NATURAL PRODUCT REPORTS, 2003, 20 (02) :243-251
[9]  
HAYMAN S, 1965, J BIOL CHEM, V240, P877
[10]   THE ROLE OF ALDOSE REDUCTASE IN THE DEVELOPMENT OF DIABETIC COMPLICATIONS [J].
KADOR, PF .
MEDICINAL RESEARCH REVIEWS, 1988, 8 (03) :325-352